<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title>Frontiers in Physiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Physiol.</abbrev-journal-title>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1209053</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2023.1209053</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Crosstalk between bone and other cells</article-title>
<alt-title alt-title-type="left-running-head">Charoenphandhu et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphys.2023.1209053">10.3389/fphys.2023.1209053</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Charoenphandhu</surname>
<given-names>Narattaphol</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1781365/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chanpaisaeng</surname>
<given-names>Krittikan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1781241/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Teerapornpuntakit</surname>
<given-names>Jarinthorn</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2304439/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wongdee</surname>
<given-names>Kannikar</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1782074/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Center of Calcium and Bone Research (COCAB)</institution>, <institution>Faculty of Science</institution>, <institution>Mahidol University</institution>, <addr-line>Bangkok</addr-line>, <country>Thailand</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Physiology</institution>, <institution>Faculty of Science</institution>, <institution>Mahidol University</institution>, <addr-line>Bangkok</addr-line>, <country>Thailand</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Molecular Biosciences</institution>, <institution>Mahidol University</institution>, <addr-line>Nakhon Pathom</addr-line>, <country>Thailand</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>The Academy of Science</institution>, <institution>The Royal Society of Thailand</institution>, <addr-line>Bangkok</addr-line>, <country>Thailand</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>National Center for Genetic Engineering and Biotechnology (BIOTEC)</institution>, <institution>National Science and Technology Development Agency</institution>, <addr-line>Pathum Thani</addr-line>, <country>Thailand</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Physiology</institution>, <institution>Faculty of Medical Science</institution>, <institution>Naresuan University</institution>, <addr-line>Phitsanulok</addr-line>, <country>Thailand</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Faculty of Allied Health Sciences</institution>, <institution>Burapha University</institution>, <addr-line>Chonburi</addr-line>, <country>Thailand</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/29565/overview">Laurence Vico</ext-link>, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale (INSERM), France</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/542105/overview">Guillaume Courbon</ext-link>, Northwestern Medicine, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Kannikar Wongdee, <email>kannikar@go.buu.ac.th</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1209053</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>04</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>05</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Charoenphandhu, Chanpaisaeng, Teerapornpuntakit and Wongdee.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Charoenphandhu, Chanpaisaeng, Teerapornpuntakit and Wongdee</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Physiol." xlink:href="https://www.frontiersin.org/researchtopic/38355" ext-link-type="uri">Editorial on the Research Topic <article-title>Crosstalk between bone and other cells</article-title>
</related-article>
<kwd-group>
<kwd>bone</kwd>
<kwd>calcium</kwd>
<kwd>immune cells</kwd>
<kwd>maternal bone metabolism</kwd>
<kwd>myokine</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Skeletal Physiology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Communications between osseous tissues and other organs are very common and essential for physiology of overall body system. For example, osteoblasts and osteocytes&#x2014;now as endocrine cells (<xref ref-type="fig" rid="F1">Figure 1</xref>)&#x2014;are able to produce and release fibroblast growth factor (FGF)-23, which, in turn, regulates renal phosphate reabsorption (<xref ref-type="bibr" rid="B22">Vervloet, 2019</xref>; <xref ref-type="bibr" rid="B1">Agoro and White, 2023</xref>) and calcium transport across the intestinal epithelium (<xref ref-type="bibr" rid="B13">Khuituan et al., 2012</xref>; <xref ref-type="bibr" rid="B19">Rodrat et al., 2018</xref>; <xref ref-type="bibr" rid="B26">Wongdee et al., 2018</xref>; <xref ref-type="bibr" rid="B25">Wongdee et al., 2021</xref>). FGF-23 also downregulates the expression and activity of 25-hydroxyvitamin D 1&#x3b1;-hydroxylase (CYP27B1) in the renal proximal tubular cells, thereby reducing the action of 1,25-dihydroxyvitamin D<sub>3</sub> (<xref ref-type="bibr" rid="B18">Perwad et al., 2007</xref>). During acute inflammation, osteocytes release certain mediators including C-terminal FGF-23 peptides to modulate hepatic hepcidin production and serum iron (<xref ref-type="bibr" rid="B7">Courbon et al., 2023</xref>). Moreover, osteocalcin or &#x3b3;-carboxyglutamic acid-containing protein&#x2014;as an osteoblast-derived endocrine factor&#x2014;is capable of regulating pancreatic insulin production (<xref ref-type="bibr" rid="B14">Lee et al., 2007</xref>), adiponectin release from adipocytes (<xref ref-type="bibr" rid="B14">Lee et al., 2007</xref>) or testicular androgen biosynthesis (<xref ref-type="bibr" rid="B12">Karsenty and Oury, 2014</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Crosstalks between bone and other organs or cells. Osteoblasts and/or osteocytes are considered endocrine cells that produce a number of bioactive molecules, e.g., osteocalcin, FGF-23 and sclerostin (see text for details). Some tissues or cells such as skeletal muscle, brain, immune cells, <italic>etc.</italic>, also produce bioactive molecules to modulate bone turnover. Arrows indicate communication, modulation and/or regulation. iFGF-23, intact fibroblast growth factor-23; Cter-FGF-23, C-terminal FGF-23 peptide.</p>
</caption>
<graphic xlink:href="fphys-14-1209053-g001.tif"/>
</fig>
<p>On the other hand, several tissues, such as muscle and brain, also send signals to modulate bone remodeling (<xref ref-type="bibr" rid="B20">Rousseaud et al., 2016</xref>; <xref ref-type="bibr" rid="B10">Gomarasca et al., 2020</xref>). For instance, myokines (e.g., interleukin-6 and irisin) have been reported to positively regulate bone formation (<xref ref-type="bibr" rid="B10">Gomarasca et al., 2020</xref>), whereas central sympathetic outflow probably enhances bone resorption through &#x3b2;<sub>2</sub>-adrenergic receptor (<xref ref-type="bibr" rid="B2">Bonnet et al., 2008</xref>; <xref ref-type="bibr" rid="B11">Huang et al., 2009</xref>). Certain organs such as lung and kidney are principal regulators of plasma pH, a disturbance of which (e.g., metabolic acidosis) profoundly affects intestinal calcium absorption (<xref ref-type="bibr" rid="B6">Charoenphandhu et al., 2007</xref>) and osteoblast-mediated bone formation (<xref ref-type="bibr" rid="B4">Bushinsky and Krieger, 2022</xref>).</p>
<p>In the present Research Topic, there are publications that clearly point out the crosstalk between bone and some other tissues and cells, including the respiratory tissues, adipose tissue, mammary tissue, brain, and immune cells (e.g., monocytes, T-cells, <italic>etc.</italic>). Specifically, in an original article by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2022.1029130/full">Ivanova et al.</ext-link>, the results corroborated that a disruption of Wnt-sclerostin pathway contributed to osteopathy (i.e., osteopenia and osteoporosis) in patients with Gaucher&#x2019;s disease, a common lysosomal storage disease caused by acid &#x3b2;-glucocerebrosidase gene mutation with cellular accumulation of glucocerebroside. Another original article by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphys.2022.1061715/full">Kurgan et al.</ext-link> demonstrated the effects of treadmill exercise on serum sclerostin levels in male mice. Sclerostin has been recognized as a secretory glycoprotein that strongly negates bone formation (<xref ref-type="bibr" rid="B8">Delgado-Calle et al., 2017</xref>; <xref ref-type="bibr" rid="B15">Liao et al., 2022</xref>), especially during mechanical unloading (<xref ref-type="bibr" rid="B16">Lin et al., 2009</xref>). It is predominantly expressed by osteocytes in order to suppress osteogenesis by regulating proliferation, differentiation, mineralization and apoptosis of osteoblasts (<xref ref-type="bibr" rid="B24">Winkler et al., 2003</xref>; <xref ref-type="bibr" rid="B21">van Bezooijen et al., 2004</xref>; <xref ref-type="bibr" rid="B15">Liao et al., 2022</xref>). Sclerostin is also expressed in some other tissues, e.g., cartilage, heart, kidney, and liver as well (<xref ref-type="bibr" rid="B3">Brunkow et al., 2001</xref>; <xref ref-type="bibr" rid="B23">Weivoda et al., 2017</xref>). Since Kurgan and others (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphys.2022.1061715/full">Kurgan et al.</ext-link>) assessed serum sclerostin in exercising male mice and found a decrease in serum sclerostin in exercising group, mechanical loading during exercise is probably an efficient way to restrict sclerostin secretion from both osteocytes and adipose tissue (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphys.2022.1061715/full">Kurgan et al.</ext-link>; <xref ref-type="bibr" rid="B17">Oniszczuk et al., 2022</xref>).</p>
<p>Generally, Wnt/&#x3b2;-catenin signaling plays a critical role in bone homeostasis by promoting osteoblastogenesis and bone formation. On the other hand, sclerostin&#x2014;known as a Wnt signaling antagonist&#x2014;binds to Wnt co-receptors, i.e., low-density lipoprotein receptor-related proteins 5 and 6 (LRP5 and LRP6), thereby preventing Wnt from binding to these co-receptor proteins. As a consequence, sclerostin blocks the Wnt downstream signaling pathway and downregulates the expression of genes involved in osteoblast commitment, such as <italic>RUNX2</italic> (<xref ref-type="bibr" rid="B8">Delgado-Calle et al., 2017</xref>). Several factors have been reported to suppress the expression of sclerostin including parathyroid hormone, estrogen as well as mechanical loading (<xref ref-type="bibr" rid="B9">Drake and Khosla, 2017</xref>). These factors thus act in concert with the Wnt/&#x3b2;-catenin signaling pathway to modulate bone homeostasis.</p>
<p>This Research Topic also contains review and mini-review articles that elaborate the crosstalk between bone and other tissues. Specifically, Ma and others (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphys.2022.939253/full">Ma et al.</ext-link>) explained how pulmonary tuberculosis, lung cancers, pollutant exposure [including particulate matter 2.5 (PM<sub>2.5</sub>)], asthma and chronic obstructive pulmonary disease are able to cause or aggravate osteoporosis. In a mini-review by <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2022.1019864/full">He and Jiang</ext-link>, the interdependent interactions between immune cells (e.g., T cells, macrophages, NK cells, and dendritic cells) and cancer cells in bone microenvironment are well delineated. Lastly, <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphys.2023.1121579/full">Athonvarangkul and Wysolmerski</ext-link> discussed the physiological significances of the brain&#x2013;breast&#x2013;bone axis and maternal skeletal changes. A maternal pathological condition known as pregnancy/lactation-associated osteoporosis was also mentioned. Maternal central nervous system&#x2014;particularly hypothalamus&#x2014;controls bone metabolism by altering a number of humoral factors, e.g., prolactin, oxytocin and gonadotropin-releasing hormone, the latter of which is the salient regulator of circulating gonadotropins and estrogen. Prolactin not only enhances the intestinal calcium absorption (<xref ref-type="bibr" rid="B5">Charoenphandhu et al., 2009</xref>) but also modulates the expression of osteoblast-derived osteoclastogenic factors (<xref ref-type="bibr" rid="B27">Wongdee et al., 2011</xref>) and sclerostin production (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphys.2023.1121579/full">Athonvarangkul and Wysolmerski</ext-link>).</p>
<p>Therefore, the present Research Topic is certainly able to shed some light on the crosstalks between bone and other distant cells, especially in lung and adipose tissue as well as cells in the brain&#x2013;breast&#x2013;bone axis (<xref ref-type="fig" rid="F1">Figure 1</xref>). Indeed, interactions between bone cells and neighboring hematopoietic cells or stem cells within marrow tissue microenvironment are not uncommon and their detailed signaling networks are worth exploring.</p>
</body>
<back>
<sec id="s1">
<title>Author contributions</title>
<p>All authors listed have made a substantial, direct, and contribution to the work and approved it for publication.</p>
</sec>
<sec id="s2">
<title>Funding</title>
<p>NC is supported by Mahidol University [Fundamental Fund: fiscal year 2022 by National Science Research and Innovation Fund (NSRF)], and the National Research Council of Thailand&#x2013;Mahidol University Grant (Distinguished Research Professor Grant). KW is supported by Burapha University, Thailand Science Research and Innovation (TSRI), and National Science Research and Innovation Fund (NSRF) (Fundamental Fund: Grant no. 41/2566).</p>
</sec>
<ack>
<p>We thank Thitapha Kiattisirichai for artwork.</p>
</ack>
<sec sec-type="COI-statement" id="s3">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s4">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agoro</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>K. E.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Regulation of FGF23 production and phosphate metabolism by bone-kidney interactions</article-title>. <source>Nat. Rev. Nephrol.</source> <volume>19</volume> (<issue>3</issue>), <fpage>185</fpage>&#x2013;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1038/s41581-022-00665-x</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonnet</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Benhamou</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Malaval</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Goncalves</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vico</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Eder</surname>
<given-names>V.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions</article-title>. <source>J. Cell Physiol.</source> <volume>217</volume> (<issue>3</issue>), <fpage>819</fpage>&#x2013;<lpage>827</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.21564</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brunkow</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Van Ness</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Paeper</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Kovacevich</surname>
<given-names>B. R.</given-names>
</name>
<name>
<surname>Proll</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Bone dysplasia sclerosteosis results from loss of the <italic>SOST</italic> gene product, a novel cystine knot-containing protein</article-title>. <source>Am. J. Hum. Genet.</source> <volume>68</volume> (<issue>3</issue>), <fpage>577</fpage>&#x2013;<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1086/318811</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bushinsky</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Krieger</surname>
<given-names>N. S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Effects of acid on bone</article-title>. <source>Kidney Int.</source> <volume>101</volume> (<issue>6</issue>), <fpage>1160</fpage>&#x2013;<lpage>1170</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2022.02.032</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charoenphandhu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nakkrasae</surname>
<given-names>L. I.</given-names>
</name>
<name>
<surname>Kraidith</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Teerapornpuntakit</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Thongchote</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Thongon</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Two-step stimulation of intestinal Ca<sup>2&#x2b;</sup> absorption during lactation by long-term prolactin exposure and suckling-induced prolactin surge</article-title>. <source>Am. J. Physiol. Endocrinol. Metab.</source> <volume>297</volume> (<issue>3</issue>), <fpage>E609</fpage>&#x2013;<lpage>E619</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00347.2009</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charoenphandhu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wongdee</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tudpor</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pandaranandaka</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Krishnamra</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Chronic metabolic acidosis upregulated claudin mRNA expression in the duodenal enterocytes of female rats</article-title>. <source>Life Sci.</source> <volume>80</volume> (<issue>19</issue>), <fpage>1729</fpage>&#x2013;<lpage>1737</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2007.01.063</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Courbon</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Martinez Calle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Spindler</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Von Drasek</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation</article-title>. <source>Blood</source> <volume>2022</volume>, <fpage>18475</fpage>. <pub-id pub-id-type="doi">10.1182/blood.2022018475</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delgado-Calle</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>A. Y.</given-names>
</name>
<name>
<surname>Bellido</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Role and mechanism of action of sclerostin in bone</article-title>. <source>Bone</source> <volume>96</volume>, <fpage>29</fpage>&#x2013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2016.10.007</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drake</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Khosla</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Hormonal and systemic regulation of sclerostin</article-title>. <source>Bone</source> <volume>96</volume>, <fpage>8</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2016.12.004</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomarasca</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Banfi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lombardi</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Myokines: The endocrine coupling of skeletal muscle and bone</article-title>. <source>Adv. Clin. Chem.</source> <volume>94</volume>, <fpage>155</fpage>&#x2013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/bs.acc.2019.07.010</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>H. H.</given-names>
</name>
<name>
<surname>Brennan</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>Muir</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Mason</surname>
<given-names>R. S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Functional &#x3b1;<sub>1</sub>-and &#x3b2;<sub>2</sub>-adrenergic receptors in human osteoblasts</article-title>. <source>J. Cell Physiol.</source> <volume>220</volume> (<issue>1</issue>), <fpage>267</fpage>&#x2013;<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.21761</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karsenty</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Oury</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Regulation of male fertility by the bone-derived hormone osteocalcin</article-title>. <source>Mol. Cell Endocrinol.</source> <volume>382</volume> (<issue>1</issue>), <fpage>521</fpage>&#x2013;<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2013.10.008</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khuituan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Teerapornpuntakit</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wongdee</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Suntornsaratoon</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Konthapakdee</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sangsaksri</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Fibroblast growth factor-23 abolishes 1,25-dihydroxyvitamin D<sub>3</sub>-enhanced duodenal calcium transport in male mice</article-title>. <source>Am. J. Physiol. Endocrinol. Metab.</source> <volume>302</volume> (<issue>8</issue>), <fpage>E903</fpage>&#x2013;<lpage>E913</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00620.2011</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Sowa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hinoi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ferron</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Confavreux</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Endocrine regulation of energy metabolism by the skeleton</article-title>. <source>Cell</source> <volume>130</volume> (<issue>3</issue>), <fpage>456</fpage>&#x2013;<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2007.05.047</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liao</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Sclerostin is a promising therapeutic target for oral inflammation and regenerative dentistry</article-title>. <source>J. Transl. Med.</source> <volume>20</volume> (<issue>1</issue>), <fpage>221</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-022-03417-4</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling</article-title>. <source>J. Bone Min. Res.</source> <volume>24</volume> (<issue>10</issue>), <fpage>1651</fpage>&#x2013;<lpage>1661</lpage>. <pub-id pub-id-type="doi">10.1359/jbmr.090411</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oniszczuk</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kaczmarek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kaczmarek</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cia&#x142;owicz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Arslan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>A. F.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Sclerostin as a biomarker of physical exercise in osteoporosis: A narrative review</article-title>. <source>Front. Endocrinol. (Lausanne).</source> <volume>13</volume>, <fpage>954895</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2022.954895</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perwad</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Tenenhouse</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Portale</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism <italic>in vivo</italic> and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression <italic>in vitro</italic>
</article-title>. <source>Am. J. Physiol. Ren. Physiol.</source> <volume>293</volume> (<issue>5</issue>), <fpage>F1577</fpage>&#x2013;<lpage>F1583</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00463.2006</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrat</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wongdee</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Panupinthu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Thongbunchoo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Teerapornpuntakit</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Krishnamra</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Prolonged exposure to 1,25(OH)<sub>2</sub>D<sub>3</sub> and high ionized calcium induces FGF-23 production in intestinal epithelium-like caco-2 monolayer: A local negative feedback for preventing excessive calcium transport</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>640</volume>, <fpage>10</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2017.12.022</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rousseaud</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Moriceau</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramos-Brossier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Oury</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Bone-brain crosstalk and potential associated diseases</article-title>. <source>Horm. Mol. Biol. Clin. Investig.</source> <volume>28</volume> (<issue>2</issue>), <fpage>69</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1515/hmbci-2016-0030</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Bezooijen</surname>
<given-names>R. L.</given-names>
</name>
<name>
<surname>Roelen</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Visser</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>van der Wee-Pals</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>de Wilt</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Karperien</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist</article-title>. <source>J. Exp. Med.</source> <volume>199</volume> (<issue>6</issue>), <fpage>805</fpage>&#x2013;<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20031454</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vervloet</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Renal and extrarenal effects of fibroblast growth factor 23</article-title>. <source>Nat. Rev. Nephrol.</source> <volume>15</volume> (<issue>2</issue>), <fpage>109</fpage>&#x2013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1038/s41581-018-0087-2</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weivoda</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Youssef</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Oursler</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Sclerostin expression and functions beyond the osteocyte</article-title>. <source>Bone</source> <volume>96</volume>, <fpage>45</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.bone.2016.11.024</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winkler</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Sutherland</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Geoghegan</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hayes</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Skonier</surname>
<given-names>J. E.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Osteocyte control of bone formation via sclerostin, a novel BMP antagonist</article-title>. <source>EMBO J.</source> <volume>22</volume> (<issue>23</issue>), <fpage>6267</fpage>&#x2013;<lpage>6276</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/cdg599</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wongdee</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chanpaisaeng</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Teerapornpuntakit</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Charoenphandhu</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Intestinal calcium absorption</article-title>. <source>Compr. Physiol.</source> <volume>11</volume> (<issue>3</issue>), <fpage>2047</fpage>&#x2013;<lpage>2073</lpage>. <pub-id pub-id-type="doi">10.1002/cphy.c200014</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wongdee</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rodrat</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Keadsai</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jantarajit</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Teerapornpuntakit</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Thongbunchoo</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Activation of calcium-sensing receptor by allosteric agonists cinacalcet and AC-265347 abolishes the 1,25(OH)<sub>2</sub>)D<sub>3</sub>-induced Ca<sup>2&#x2b;</sup> transport: Evidence that explains how the intestine prevents excessive Ca<sup>2&#x2b;</sup> absorption</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>657</volume>, <fpage>15</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2018.09.004</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wongdee</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tulalamba</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Thongbunchoo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Krishnamra</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Charoenphandhu</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Prolactin alters the mRNA expression of osteoblast-derived osteoclastogenic factors in osteoblast-like UMR106 cells</article-title>. <source>Mol. Cell Biochem.</source> <volume>349</volume> (<issue>1&#x2013;2</issue>), <fpage>195</fpage>&#x2013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-010-0674-4</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>